miR-411-3p 203, 204 targets Smurf2 to inhibit the activation of the TGF-β/smad signaling pathway and thereby inhibit bleomycin-induced dermal fibrosis and silica-induced pulmonary fibrosis. The gene discussed is SMURF2; the disease is pulmonary fibrosis.